Related Experiment Video

Updated: Jul 20, 2026

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
10:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

Lipoprotein-associated phospholipase A2

Joseph P McConnell1, Daniel M Hoefner

  • 1Department of Laboratory Medicine and Pathology, The Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA. mcconnell.joseph@mayo.edu

Clinics in Laboratory Medicine
|August 30, 2006
PubMed

Insights

Lipoprotein-associated phospholipase A2 (LP-PLA2) is an inflammatory marker linked to cardiovascular disease (CVD) risk. Research explores LP-PLA2

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Inflammation Research

Background:

  • Lipoprotein-associated phospholipase A2 (LP-PLA2) is an emerging inflammatory marker associated with cardiovascular disease (CVD) risk.
  • Epidemiologic studies show a correlation between plasma LP-PLA2 levels and cardiovascular event risk.
  • Current treatments like statins and fenofibrates can lower LP-PLA2 concentrations.

Purpose of the Study:

  • To review recent studies on LP-PLA2 in the context of CVD.
  • To discuss the proposed mechanisms of action for LP-PLA2.
  • To describe methods for measuring LP-PLA2 and their clinical applications.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Analysis of proposed biochemical pathways involving LP-PLA2.
  • Evaluation of diagnostic and clinical utility of LP-PLA2 measurement techniques.

Main Results:

  • LP-PLA2 concentration is independently associated with cardiovascular event risk.
  • Statins and fenofibrates demonstrate efficacy in reducing plasma LP-PLA2 levels.
  • Specific LP-PLA2 inhibitors are under clinical investigation as a therapeutic strategy.

Conclusions:

  • LP-PLA2 is a significant marker for assessing CVD risk.
  • LP-PLA2 presents a potential therapeutic target for cardiovascular conditions.
  • Further research is ongoing to validate LP-PLA2 inhibitors in clinical practice.

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes08:49

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes

Published on: March 14, 2021

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids as Anchors01:32

Lipids as Anchors

In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...